Xianjun Yu
Ningbo University(CN)Zhejiang Chinese Medical University(CN)Hunan University of Science and Technology(CN)Hubei University of Medicine(CN)Fujian Medical University(CN)Nanjing University of Chinese Medicine(CN)Shanghai Medical College of Fudan University(CN)Hunan University of Traditional Chinese Medicine(CN)Guizhou University(CN)Shanghai Jiao Tong University(CN)Dalian Medical University(CN)Chinese Academy of Medical Sciences & Peking Union Medical College(CN)Ministry of Ecology and Environment(CN)Fudan University(CN)Art Gallery of New South Wales(AU)Cancer Institute (WIA)(IN)UNSW Sydney(AU)Soochow University(CN)National Cancer Center(US)Fudan University Shanghai Cancer Center(CN)Second Affiliated Hospital of Chongqing Medical University(CN)Zhejiang Cancer Hospital(CN)Sichuan Mianyang 404 Hospital(CN)Shanghai Cancer Institute(CN)Sanming University(CN)Ningbo University Affiliated Hospital(CN)Nanjing Jiangning Hospital(CN)Second Affiliated Hospital of Zhejiang University(CN)Ningbo First Hospital(CN)Chongqing University of Technology(CN)Chongqing Medical University(CN)
Publications by Year
Research Areas
Pancreatic and Hepatic Oncology Research, Neuroendocrine Tumor Research Advances, Lung Cancer Research Studies, Neuroblastoma Research and Treatments, Cancer Genomics and Diagnostics
Most-Cited Works
- → Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives(2021)2,188 cited
- → Ferroptosis, necroptosis, and pyroptosis in anticancer immunity(2020)1,325 cited
- → The role of necroptosis in cancer biology and therapy(2019)1,058 cited
- → Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research(2022)788 cited
- → The role of collagen in cancer: from bench to bedside(2019)741 cited
- → Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype(2017)693 cited